Mihaela Bet

Class of 2023-2024

Trinity College Dublin

Why did you choose ESTEEM?

I chose ESTEEM because I wanted to pursue a degree where I could combine my technical background with creative and analytical thinking, while also broadening my horizons beyond academia. ESTEEM offers a comprehensive program that offers a wide range of experiences from technical electives such as nanomedicine to the Capstone project, providing a challenging and well-rounded educational and professional experience.

What is your Capstone Project and why are you excited about it?

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare genetic diseases. Amicus is comprehensively investigating opportunities for a series of rare disorders through a multifaceted approach, including evaluating the market potential and assessing Amicus’ technological, research and development, and commercial capabilities to explore the feasibility of venturing into new therapeutic spaces. A crucial aspect of this endeavor involves engaging directly with physicians, patients, and research experts. This collaborative approach allows for invaluable insights into the unmet need and the potential of new therapies. The primary objective of this capstone project is to determine if an unmet demand for novel therapeutic solutions exists within a specific rare genetic disorder domain. With this approach, Amicus Therapeutics remains committed to advancing science and therapeutics for patients who show true unmet healthcare needs

What do you hope to do after ESTEEM?

After ESTEEM, I hope to contribute to advancements in the biotechnology or healthcare industry so that patients can live happier, better lives.

What do you like to do in your free time?

When I'm not working I like to catch up with friends and enjoy good food!

Connect on LinkedIn